The 20 Best Retinal Artery Occlusion Doctors in Maryland, US

Allen Hu is an Ophthalmologist in Cumberland, Maryland. Dr. Hu is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Vitrectomy.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Joseph Harlan is an Ophthalmologist in Lutherville Timonium, Maryland. Dr. Harlan is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Artery Occlusion, and Age-Related Macular Degeneration (ARMD).

James Rial is an Ophthalmologist in Salisbury, Maryland. Dr. Rial is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Artery Occlusion, and Diabetic Retinopathy.

Joseph Schwartz is an Ophthalmologist in Salisbury, Maryland. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Retinal Artery Occlusion.

Michael Grodin is an Ophthalmologist in Lutherville Timonium, Maryland. Dr. Grodin is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion.

Michael Elman is an Ophthalmologist in Rosedale, Maryland. Dr. Elman is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy. Dr. Elman is currently accepting new patients.

Robert Parnes is an Ophthalmologist in Hagerstown, Maryland. Dr. Parnes is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion.

Paul Lagonigro is an Ophthalmologist in Salisbury, Maryland. Dr. Lagonigro is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Retinal Detachment.

Adam Gerstenblith is an Ophthalmologist in Hagerstown, Maryland. Dr. Gerstenblith is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Vitrectomy.

Deborah Reid is an Ophthalmologist in Annapolis, Maryland. Dr. Reid is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion.

John Butler is an Ophthalmologist in Salisbury, Maryland. Dr. Butler is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Artery Occlusion, Retinal Vein Occlusion, and Vitrectomy.

Jordan Heffez is an Ophthalmologist in Bethesda, Maryland. Dr. Heffez is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, X-Linked Juvenile Retinoschisis, X-Linked Retinal Dysplasia, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Fadi Nasrallah is an Ophthalmologist in Bethesda, Maryland. Dr. Nasrallah is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Neuroretinitis, Retinal Vein Occlusion, and Central Serous Chorioretinopathy.

Joshua Fernandes is an Ophthalmologist in Silver Spring, Maryland. Dr. Fernandes is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Gyrate Atrophy of the Choroid and Retina.

Adrienne W. Scott, M.D, is a retina specialist and the Fred M. Leader Family Retina Professor of ophthalmology at the Wilmer Eye Institute's locations in Baltimore and Bel Air, Maryland. Dr. Scott treats patients across the spectrum of vitreoretinal medical and surgical diseases, including macular degeneration, diabetic retinopathy, retinal detachments and more. Dr. Scott received her doctor of medicine degree from Drexel University College of Medicine in Philadelphia, Pennsylvania and completed her ophthalmology residency at the Duke University Eye Center. During her residency, Dr. Scott received the Ocular Innovation Award, the K. Alexander Dastgheib Eye Surgery Award and the Edward K. Isbey, Jr. M.D. Award for clinical excellence. She remained at the Duke Eye Center to complete her two-year fellowship training in vitreoretinal surgery prior to joining the Wilmer faculty. Dr. Scott is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.